RU93053489A - PHARMACEUTICAL COMPOSITION OF ANTI-ALCOHOLIC, STIMULATING ENERGY METABOLISM, ACID-FORMING AND SECRETARY FUNCTION OF THE Mucous Stomach, RADIO PROTECTIVE AND ANTI-CHEMOLAR - Google Patents

PHARMACEUTICAL COMPOSITION OF ANTI-ALCOHOLIC, STIMULATING ENERGY METABOLISM, ACID-FORMING AND SECRETARY FUNCTION OF THE Mucous Stomach, RADIO PROTECTIVE AND ANTI-CHEMOLAR

Info

Publication number
RU93053489A
RU93053489A RU93053489/14A RU93053489A RU93053489A RU 93053489 A RU93053489 A RU 93053489A RU 93053489/14 A RU93053489/14 A RU 93053489/14A RU 93053489 A RU93053489 A RU 93053489A RU 93053489 A RU93053489 A RU 93053489A
Authority
RU
Russia
Prior art keywords
acid
forming
energy metabolism
pharmaceutical composition
chemolar
Prior art date
Application number
RU93053489/14A
Other languages
Russian (ru)
Other versions
RU2039556C1 (en
Inventor
И.А. Комиссарова
Ю.В. Гудкова
Т.Д. Солдатенкова
Н.М. Бурбенская
Т.Т. Кондрашова
И.Л. Калантар
Ю.М. Торопов
Г.Ф. Семенова
Р.П. Нарциссов
Е.В. Калинина
Original Assignee
И.А. Комиссарова
Ю.В. Гудкова
Т.Д. Солдатенкова
Н.М. Бурбенская
Т.Т. Кондрашова
И.Л. Калантар
Ю.М. Торопов
Г.Ф. Семенова
Р.П. Нарциссов
Е.В. Калинина
Filing date
Publication date
Priority claimed from PCT/RU1992/000134 external-priority patent/WO1994001099A1/en
Application filed by И.А. Комиссарова, Ю.В. Гудкова, Т.Д. Солдатенкова, Н.М. Бурбенская, Т.Т. Кондрашова, И.Л. Калантар, Ю.М. Торопов, Г.Ф. Семенова, Р.П. Нарциссов, Е.В. Калинина filed Critical И.А. Комиссарова
Priority to RU9393053489A priority Critical patent/RU2039556C1/en
Application granted granted Critical
Publication of RU2039556C1 publication Critical patent/RU2039556C1/en
Publication of RU93053489A publication Critical patent/RU93053489A/en

Links

Claims (1)

Фармацевтическая композиция противоалкогольного, стимулирующего энергетический обмен, кислотообразующую и секреторную функцию слизистой желудка, радиопротекторного и противохолерного действия содержит в качестве действующего вещества смесь янтарной и лимонной кислот или их фармацевтически приемлемых солей. Способ профилактики и лечения алкогольного опьянения и алкогольного абстинентного синдрома, стимуляции энергетического обмена, стимуляции и диагностики кислотообразующей и секреторной функции слизистой желудка, защиты от радиационного поражения и профилактики холеры заключается в пероральном введении эффективного количества предлагаемой композиции.The pharmaceutical composition of the anti-alcohol, stimulating energy metabolism, acid-forming and secretory function of the gastric mucosa, radioprotective and anti-cholera action contains a mixture of succinic and citric acids or their pharmaceutically acceptable salts as active ingredient. A method for the prevention and treatment of alcohol intoxication and alcohol withdrawal syndrome, stimulation of energy metabolism, stimulation and diagnosis of acid-forming and secretory functions of the gastric mucosa, protection against radiation damage and prevention of cholera consists in the oral administration of an effective amount of the proposed composition.
RU9393053489A 1992-07-06 1993-07-07 Pharmaceutical antialcoholic composition stimulating energy metabolism, secretory function of gastric mucous membrane and producing halioprotective and antitumor effect; method of prevention and treatment of alcoholic intoxication and alcoholic abstinence syndrome; method for stimulating energy metabolism; method for stimulating and diagnosing acid-forming and secretory functions of gastric mucosa; method for protecting warm-blooded animals from radiation injury RU2039556C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU9393053489A RU2039556C1 (en) 1992-07-06 1993-07-07 Pharmaceutical antialcoholic composition stimulating energy metabolism, secretory function of gastric mucous membrane and producing halioprotective and antitumor effect; method of prevention and treatment of alcoholic intoxication and alcoholic abstinence syndrome; method for stimulating energy metabolism; method for stimulating and diagnosing acid-forming and secretory functions of gastric mucosa; method for protecting warm-blooded animals from radiation injury

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/RU1992/000134 WO1994001099A1 (en) 1992-07-06 1992-07-06 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions
RU9393053489A RU2039556C1 (en) 1992-07-06 1993-07-07 Pharmaceutical antialcoholic composition stimulating energy metabolism, secretory function of gastric mucous membrane and producing halioprotective and antitumor effect; method of prevention and treatment of alcoholic intoxication and alcoholic abstinence syndrome; method for stimulating energy metabolism; method for stimulating and diagnosing acid-forming and secretory functions of gastric mucosa; method for protecting warm-blooded animals from radiation injury

Publications (2)

Publication Number Publication Date
RU2039556C1 RU2039556C1 (en) 1995-07-20
RU93053489A true RU93053489A (en) 1996-09-20

Family

ID=20129719

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9393053489A RU2039556C1 (en) 1992-07-06 1993-07-07 Pharmaceutical antialcoholic composition stimulating energy metabolism, secretory function of gastric mucous membrane and producing halioprotective and antitumor effect; method of prevention and treatment of alcoholic intoxication and alcoholic abstinence syndrome; method for stimulating energy metabolism; method for stimulating and diagnosing acid-forming and secretory functions of gastric mucosa; method for protecting warm-blooded animals from radiation injury

Country Status (7)

Country Link
US (1) US5559152A (en)
EP (1) EP0617958A4 (en)
JP (1) JPH06510547A (en)
CN (1) CN1054506C (en)
AU (1) AU2330892A (en)
RU (1) RU2039556C1 (en)
WO (1) WO1994001099A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798371A (en) * 1995-01-13 1998-08-25 Komissarova; Irina Alexeevna Pharmaceutical composition endowed with an antialcoholic and nootropic effect
US6383534B1 (en) 2000-01-18 2002-05-07 Lorin Dyrr Mineral water composition
IL151411A0 (en) 2001-02-14 2003-04-10 Rath Matthias Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
WO2004112773A1 (en) * 2003-04-24 2004-12-29 Shin-Jen Shiao Pharmaceutical compositions used for immune disease treatment and improvement
UA88780C2 (en) * 2004-02-17 2009-11-25 Граф фон Матушка-Грайффенклау Маркус Alcohol metabolism moderating food composition
EA007865B1 (en) * 2005-03-01 2007-02-27 Общество С Ограниченной Ответственностью "Палисандр" Disintoxicating infusion solution
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
AU2006278823B2 (en) 2005-07-29 2011-05-12 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
CA2658804A1 (en) * 2006-07-25 2008-01-31 Vecta Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi
US20090112238A1 (en) * 2007-10-26 2009-04-30 Vance Products Inc., D/B/A Cook Urological Inc. Fistula brush device
US8058296B2 (en) * 2008-11-25 2011-11-15 Richard Tokunaga Treatment and prevention of deleterious effects associated with alcohol consumption
CN104470524A (en) * 2012-05-25 2015-03-25 拉夸里亚创药株式会社 Ghrelin receptor agonists for the treatment of achlorhydria
US10413563B2 (en) 2017-05-10 2019-09-17 Emerald Neuro-Recover, LLC Neurochemical wellness program
CN109223750A (en) * 2018-10-16 2019-01-18 中国水产科学研究院南海水产研究所 Application of the succinic acid in prevention and treatment prawn enteritis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111770A1 (en) * 1981-03-25 1982-10-07 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin USE OF DIMERCAPTOPROPANESULPHONIC ACID AND DIMERCAPTOSEMBER ACID FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
DK315482A (en) * 1981-07-20 1983-01-21 Kimberly Clark Co PROCEDURE FOR PREVENTING DISTRIBUTION OF SPIRIT WIRES AND METHOD FOR USING THE PROCEDURE
SU1090405A1 (en) * 1982-08-12 1984-05-07 Институт биологической физики АН СССР Method of intensification of energy metabolism
GB8628228D0 (en) * 1986-11-26 1986-12-31 Inst Biolog Morya Dalnevostoch Composition inhibiting pathological addiction to alcohol
SE8803144L (en) * 1988-09-07 1990-03-08 Kabivitrum Ab energy substrates

Similar Documents

Publication Publication Date Title
RU93053489A (en) PHARMACEUTICAL COMPOSITION OF ANTI-ALCOHOLIC, STIMULATING ENERGY METABOLISM, ACID-FORMING AND SECRETARY FUNCTION OF THE Mucous Stomach, RADIO PROTECTIVE AND ANTI-CHEMOLAR
RU98111594A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN
TW359614B (en) Composition containing benzimidazole compounds for rectal administration
CA2302508A1 (en) Polyanhydrides with therapeutically useful degradation products
RU93057724A (en) PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARATION AND METHOD OF TREATMENT
NZ508526A (en) Opioid formulations for treating pain
CA2070061A1 (en) Physiologically active polypeptide-containing pharmaceutical composition
TR200103613T2 (en) Pharmaceutical formulations and methods containing morphine administered intranasally.
EP1531837A1 (en) Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
EP0350701A3 (en) Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes
RU95101385A (en) Products containing g-csf and tnf-binding protein
EP0315332B1 (en) Antitussive liquid compositions containing phenol
CA2131991C (en) Treatment of migraine
RU99119233A (en) PHARMACEUTICAL COMPOSITIONS containing ibuprofen and domperidone for the treatment of migraine
WO2003089007B1 (en) Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
SE8701077L (en) PHARMACEUTICAL PREPARATION
JPH0656677A (en) Antacid composition
EG17992A (en) Preparation of a medicament for arthritis and theumatism
CA2368352A1 (en) Method for treating neurodegeneration
WHEATLEY Analgesic properties of fluproquazone
WO2001001995A3 (en) Method for treatment of asthma syndrome
RU1561262C (en) Composition showing antiinflammatory activity
WO1998057626A1 (en) Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections
US5989571A (en) Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
North et al. Comparison of butorphanol and pentazocine as postoperative analgesics